Loquinte, Char Janna M.
HRN: 27-06-17 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2025
CEFUROXIME 500MG (TAB)
05/31/2025
06/07/2025
PO
1 Tab
BID
SP Repeat CS + BTL
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines